Quantinuum revenue and financials
$44.84Change from previous close: −2.70%Absolute change: −$1.25
In the fiscal year ended December 2025, Quantinuum reported revenue of $30.93M (+34.61% year over year). The net loss was $71.53M.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +34.61%
- 2025 vs 2024
- Net margin
- -231.3%
- 2024: -627.0%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 |
|---|---|---|
| Total revenue | 30.9 | 23.0 |
| Cost of revenue | 11.7 | 10.8 |
| Gross profit | 19.2 | 12.2 |
| Selling, general and administrative | 133 | 31.3 |
| Research and development | 405 | 122 |
| Operating income | -530 | -153 |
| EBIT | -530 | -153 |
| EBITDA | -500 | -121 |
| Pre-tax income | -568 | -144 |
| Income tax | 0.1 | 0.2 |
| Net income | -71.5 | -144 |
| Net income to common shareholders | -71.5 | -144 |
| Basic EPS | -2.15 | -4.16 |
| Diluted EPS | -2.15 | -4.16 |
| Average shares (basic) | 33.2 | 34.7 |
| Average shares (diluted) | 33.2 | 34.7 |